Tinzaparin in acute ischaemic stroke trial - TAIST

Description:

Tinzaparin in acute ischaemic stroke trial (TAIST) was a randomized, controlled, double-blind trial comparing the safety and efficacy of "medium" and "high" doses of the low molecular weight heparin tinzaparin with standard strength aspirin early after an acute ischemic stroke.